122 related articles for article (PubMed ID: 668724)
1. The effect of 5-hydroxytryptamine and epinephrine on newborn platelets.
Alebouyeh M; Lusher JM; Ameri MR; Evans RK; Robinson A
Eur J Pediatr; 1978 Jul; 128(3):163-8. PubMed ID: 668724
[TBL] [Abstract][Full Text] [Related]
2. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
Serebruany VL; El Mouelhi M; Pfannkuche HJ; Rose K; Marro M; Angiolillo DJ
Am J Ther; 2010; 17(6):543-52. PubMed ID: 19797939
[TBL] [Abstract][Full Text] [Related]
3. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
Michal F; Motamed M
Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
[TBL] [Abstract][Full Text] [Related]
4. Serotonin receptor site in human platelets from control and chlorpromazine treated subjects.
Oppenheim B; Hefez A; Youdim MB
Prog Biochem Pharmacol; 1980; 16():119-32. PubMed ID: 7443729
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of aggregation of rabbit and human platelets induced by adrenaline and 5-hydroxytryptamine by KB-R7943, a Na(+)/Ca(2+) exchange inhibitor.
Takano S; Kimura J; Ono T
Br J Pharmacol; 2001 Apr; 132(7):1383-8. PubMed ID: 11264230
[TBL] [Abstract][Full Text] [Related]
6. Epinephrine potentiates human platelet activation but is not an aggregating agent.
Lanza F; Beretz A; Stierlé A; Hanau D; Kubina M; Cazenave JP
Am J Physiol; 1988 Dec; 255(6 Pt 2):H1276-88. PubMed ID: 3202191
[TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxytryptamine uptake and release in relation to aggregation of rabbit platelets.
Baumgartner HR
J Physiol; 1969 Apr; 201(2):409-23. PubMed ID: 5780550
[TBL] [Abstract][Full Text] [Related]
8. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
9. Cigarette Smoking-Associated Alterations in Serotonin/Adrenalin Signaling Pathways of Platelets.
Lowery CL; Elliott C; Cooper A; Hadden C; Sonon RN; Azadi P; Williams DK; Marsh JD; Woulfe DS; Kilic F
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28522678
[TBL] [Abstract][Full Text] [Related]
10. Effects of various ginseng saponins on 5-hydroxytryptamine release and aggregation in human platelets.
Kimura Y; Okuda H; Arichi S
J Pharm Pharmacol; 1988 Dec; 40(12):838-43. PubMed ID: 2907575
[TBL] [Abstract][Full Text] [Related]
11. The relation between the 5-hydroxytryptamine content and aggregation of rabbit platelets.
Baumgartner HR; Born GV
J Physiol; 1969 Apr; 201(2):397-408. PubMed ID: 5780549
[TBL] [Abstract][Full Text] [Related]
12. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
Connolly TM; Limbird LE
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
[TBL] [Abstract][Full Text] [Related]
13. ADP, adrenaline and serotonin stimulate inositol 1,4,5-trisphosphate production in human platelets.
Vanags DM; Lloyd JV; Rodgers SE; Bochner F
Eur J Pharmacol; 1998 Sep; 358(1):93-100. PubMed ID: 9809874
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of serotonin-induced platelet aggregation by endothelins].
Takada A; Takada Y
Nihon Rinsho; 1992 Feb; 50(2):315-8. PubMed ID: 1613985
[TBL] [Abstract][Full Text] [Related]
15. Urapidil inhibits 5-hydroxytryptamine induced platelet aggregation and 14C-5-hydroxytryptamine uptake in platelets.
Storck J; Kirsten R
Curr Med Res Opin; 1990; 12(2):86-92. PubMed ID: 2390867
[TBL] [Abstract][Full Text] [Related]
16. Studies of platelet 5-hydroxytryptamine (serotonin) in storage pool disease and albinism.
Weiss HJ; Tschopp TB; Rogers J; Brand H
J Clin Invest; 1974 Aug; 54(2):421-33. PubMed ID: 4847252
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol 3-kinase inhibitor, wortmannin, inhibits 5-hydroxytryptamine-mediated potentiation of platelet aggregation induced by epinephrine.
Shah BH; Saeed SA
Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):157-64. PubMed ID: 8556270
[TBL] [Abstract][Full Text] [Related]
18. 5-hydroxytryptamine and platelet aggregation.
De Clerck FF; Herman AG
Fed Proc; 1983 Feb; 42(2):228-32. PubMed ID: 6822293
[TBL] [Abstract][Full Text] [Related]
19. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
[TBL] [Abstract][Full Text] [Related]
20. Platelet hypersensitivity induced by cholesterol incorporation.
Shattil SJ; Anaya-Galindo R; Bennett J; Colman RW; Cooper RA
J Clin Invest; 1975 Mar; 55(3):636-43. PubMed ID: 1117069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
